Advancing CNS Therapeutics with Proteomics
Ada Yee, Benjamin Thomas September 11, 2025
Automating Oligonucleotide Drug Development
Arielle Mann August 25, 2025
Integrated Workflows for Antibody Development
Ada Yee August 25, 2025
Next-Gen Cell Line Characterization
Valentina Armiento July 23, 2025
Autologous vs. Allogeneic Cell Therapies: Key Insights
Marie-Ange Kouassi July 18, 2025
Automating MS for Faster Oligonucleotide Development
Ada Yee July 17, 2025
Biopharma Data Integration for Smarter Biologics Development
Ada Yee July 16, 2025
Precision Medicine in IMIDs - Path to Improved Healthcare Outcomes
Justyna Lisowska July 14, 2025
Clinical Trial Design Evolution: Key Trends and the Integral Role of Bioinformatics Solutions
Marie-Ange Kouassi July 10, 2025
Enhancing ROI with Long-Read Sequencing
Raed Hmadi June 16, 2025
NGS-Based Vector Integrity Confirmation for Gene Therapy Products
Genedata June 13, 2025
Advanced NGS for CLD in CGT Development
Valentina Armiento April 21, 2025
Industry Insights: GMP-Compliant NGS-Based Workflows
Raed Hmadi October 15, 2024
R&D Digitalization: Industry Perspectives from the Open Forum at EMD Serono
Jana Hersch September 19, 2024
Realize the Promise of Multi-Omics for Precision Medicine
Marie-Ange Kouassi September 1, 2024
Streamlining Computerized System Validation
Valentina Armiento May 30, 2024
Validating NGS Assays in Light of Regulatory Changes
Urszula Cendrowska April 22, 2024
Harnessing the Power of Data in the Fight Against Cancer
Genedata February 4, 2024
NGS Revolution for Establishing CQAs of CGT Products
Marie-Ange Kouassi January 30, 2024
Accelerating CGT Product Development via NGS
Urszula Cendrowska November 15, 2023
Knowledge Exchange to Accelerate Gene Therapy Product Development
Marie-Ange Kouassi June 29, 2023
Cell Therapy: The Potential for Effective Precision Medicine
Nicholas S. Geraci & Justyna Lisowska June 7, 2023
Precision Medicine in Alzheimer’s Disease – The Time Is Now!
Justyna Lisowska May 9, 2023
Unlocking the Power of Posit and R for Precision Medicine Development
Marie-Ange Kouassi & Hagen Klett February 27, 2023
Jana Hersch November 17, 2022
Genedata at Bio Japan 2022
Naho Shimoyama November 9, 2022
Uniting to Transform Biotherapeutic Product QC with NGS
Marie-Ange Kouassi October 30, 2022
Interview: Automated Screening for COVID-19 Drugs
Jasmin Lozza October 17, 2022
Collaboration and Digitalization Fuel Biopharma Innovation
Jana Hersch September 25, 2022
On the Path to Precision in Alzheimer’s Disease Management
Justyna Lisowska September 21, 2022
Foster Open Innovation for Cell Therapy Development
Justyna Lisowska July 19, 2022
Discussions on Optimizing Cell Line Development with NGS
Marie-Ange Kouassi July 18, 2022
Accelerated mAb Manufacturing: 3 Months to GMP
Marie-Ange Kouassi June 24, 2022
Using TLA for Genomic Fingerprinting of Production Cell Lines
Marie-Ange Kouassi April 24, 2022
Leveraging a Data Strategy for Improved Clinical Success Rates
Lakshmi Maithel March 29, 2022
Fireside Discussions on NGS-Based Biosafety - A Gamechanger
Marie-Ange Kouassi February 8, 2022
World Cancer Day at Genedata
Genedata February 4, 2022
Facilitating Knowledge Exchange on NGS-Based Biosafety Testing
Marie-Ange Kouassi December 9, 2021
Going Beyond a Biomarker-Driven Strategy
Justyna Lisowska November 30, 2021
Screener User Community Comes Together
Ada Yee October 13, 2021
